Cardiac allograft endothelial dysfunction

European Journal of Clinical Pharmacology

Volumn 62, Issue 1, 2006, Pages 79-82

  Kofler, Sieglinde ^a   Petrakopoulou, Paraskevi ^a   Nickel, Thomas ^a   Weis, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cytomegalovirus; Inflammation; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLOIMMUNITY; ATHEROGENESIS; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR RISK; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIAL DYSFUNCTION; GRAFT FAILURE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VASCULAR LESION; APOPTOSIS; CELL ACTIVATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; EXTRACELLULAR MATRIX; LEUKOCYTE; SMOOTH MUSCLE FIBER; THROMBOCYTE ADHESION; VASOMOTOR REFLEX;

EID: 33344478645     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0011-0     Document Type: Conference Paper

References (31)

1. Rogers N, Lechler R (2001) Allorecognition. Am J Transplant 1:97-102
2. Lechler R, Ng WF, Steinmann RM (2001) Dendritic cells in transplantation - friend or foe? Immunity 14:357-368
3. Weis M, von Scheidt W (2000) Coronary artery disease in the transplanted heart. Annu Rev Med 51:81-100
4. Schlichting CL, Schareck WD, Nickel T, Weis M (2005) Dendritic cells as pharmacological targets for the generation of regulatory immunosuppressive effectors. New implications for allo-transplantation. Curr Med Chem 12:1623-1629
5. Valujskikh A, Heeger P (2003) Emerging roles of endothelial cells in transplant rejection. Curr Opin Immunobiol 15:493-498
6. Weis M, von Scheidt W (1997) Cardiac allograft vasculopathy. A review. Circulation 96:2069-2077
7. Vassalli G, Gallino A, Weis M, von Scheidt W, Kappenberger L, von Segesser LK, Goy JJ (2003) Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 24:1180-1188
8. Valantine HA (2003) Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Transplantation 76:891-899
9. Weis M, Schlichting CL, Engleman EG, Cooke JP (2002) Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol 22:1817-1823
10. Hu Y, Davison F, Zhang Z, Xu Q (2003) Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108:3122-3127
11. Billingham ME (1992) Histopathology of graft coronary disease. J Heart Lung Transplant 11:S38-S44
12. Weis M, Wolf WP, Mazilli N, Olbrich HG, Burger W, Hartmann A (1997) Variations of segmental endothelium dependent and endothelium independent vasomotor tone in the long term follow up after cardiac transplantation (qualitative changes in endothelial function). Am Heart J 134:306-315
13. Hollenberg SM, Klein LW, Parrillo JE, Scherer M, Burns D, Tamburro P, Oberoi M, Johnson MR, Costanzo MR (2001) Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104:3091-3096
14. Weis M, Pehlivanli S, Meiser BM, von Scheidt W (2001) Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J Am Coll Cardiol 38:814-818
15. Weis M, Hartmann A, Olbrich HG, Hor G, Zeiher AM (1998) Prognostic significance of coronary flow reserve on left ventricular ejection fraction in cardiac transplant recipients. Transplantation 65:103-108
16. Shears LL, Kawaharada N, Tzeng E, Billar TR, Watkins SC, Kovesdi I, Lizonova A, Pham SM (1997) Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 100:2035-2042
17. Minamoto K, Pinsky D (2002) Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts. J Exp Med 196:1321-1333
18. Wildhirt SM, Weis M, Schulze C, Conrad N, Pehlivanli S, Rieder G, Enders G, von Scheidt W, Reichart B (2001) Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts. Circulation 104:1336-1343
19. Weis M, Cooke JP (2003) Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Arterioscler Thromb Vasc Biol 23:567-575
20. Lee PC, Wang ZL, Qian S, Watkins SC, Lizonova A, Kovesdi I, Tzeng E, Simmons RL, Billiar TR, Shears LL II (2000) Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation 69:1186-1192
21. Iwata A, Sai S, Moore M, Nyhuis J, de Fries-Hallstrand R, Quetingco GC, Allen MD (2000) Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase. J Heart Lung Transplant 19:1017-1028
22. Vejlstrup NG, Andersen CB, Boesgaard S, Mortensen SA, Aldershvile J (2002) Temporal changes in myocardial endothelial nitric oxide synthase expression following human heart transplantation. J Heart Lung Transplant 21:206-211
23. Weis M, Wildhirt SM, Schulze C, Pehlivanli S, Rieder G, Wolf WP, Wilbert-Lampen U, Meiser BM, Enders G, von Scheidt W (2000) Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens. J Cardiovasc Pharmacol 36:776-784
24. Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, Kushwaha SS, Caplice NM (2003) Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 108:143-149
25. Hosenpud JD (1999) Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J 138:S469-S742
26. Knight DA, Briggs BR, Bennett CF, Harindranath N, Waldman WJ, Sedmak DD (2000) Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2′-O-methoxyethyl antisense oligonucleotide. Transplantation 69:417-426
27. Grattan MT, Moreno-Cabral CE, Stames VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc 261:3561-3566
28. Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW Jr, Merigan TC, Schroeder JS (1999) Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 100:61-66
29. Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, Valantine HA, Mocarski ES, Cooke JP (2004) Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 109:500-505
30. Cooke J (2000) Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20:2032-2036
31. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M (2004) Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 110(11 Suppl 1):II207-II212